ESG

How the luxury tourism developer is pioneering data governance to comply with new Saudi laws and power its vision for regenerative tourism.

Aspen Midstream's new 3 Bcf/d Katy Hub will connect Texas gas supply to soaring LNG, power, and industrial demand, reshaping the Gulf Coast energy map.

An upstate NY startup just won "Water Bottle of the Year" by solving a critical safety issue with an innovative, eco-conscious design.

Czech MedTech firm Stimvia builds a scientific and commercial 'dream team' to launch its non-invasive URIS® therapy for overactive bladder worldwide.

A new venture backed by Cerberus and Eos aims to fast-track U.S. energy storage with a novel model combining capital, tech, and insurance.

Private equity firm Thurston Group launches Sensorium Clinical Research, a new network aiming to unify top trial sites and streamline medical innovation.

Chinese giant Changan targets a top-5 MEA market rank by 2030, shifting from exports to deep local investment with its ambitious Vast Ocean Plan 2.0.

Fourier and Intel reveal how modular, liquid-cooled systems are replacing components to power the next wave of AI, making deployment speed the ultimate weapon.

China's Weichai Power has earned a top global quality award, a first for its industry, signaling a major shift in high-end manufacturing standards.

Epson's new AM-C10000 inkjet MFP boasts 100ppm speeds and 93% less energy use, aiming to redefine high-volume office printing and sustainability.

Packaging giant Huhtamäki repurchases its sustainability-linked bonds at a premium, signaling financial savvy and strong investor confidence.

Using subatomic particles from deep space, Power Metallic aims to unlock a new frontier of mineral wealth deep beneath its Quebec polymetallic project.

Paula Daniels brings her unique expertise in sustainable food systems to the MWD board, signaling a major shift toward integrating water and food security.

Strong Q1 results driven by Australian operations and a record gas compression backlog, offsetting a cautious North American drilling market.

The medical device maker posts its 14th straight growth quarter, with soaring profits and a strategic focus on the underserved bronchiectasis market.

Grupo Nutresa posted a 42% EBITDA surge, but a strong peso and rising financial costs pushed its reported net income into the red. What's behind the numbers?

With a novel drug for schizophrenia and deep financial backing, LB Pharmaceuticals is advancing a promising new therapy for complex mental illnesses.

South Jersey Industries offers to buy back $287.5M in notes for just 9 cents on the dollar, forcing a tough choice on bondholders. What's behind the move?

With its first patient enrolled and key EU approvals, Inhibikase pushes its PAH drug IKT-001 forward, balancing clinical hope with financial realities.

The cell-engineering firm posted a smaller-than-expected loss and announced a share buyback, signaling confidence despite a dip in core Q1 revenue.